Skip to main content
graph.swiss
Fresenius Medical Care AG

Fresenius Medical Care AG

38.22 CHF+0.00 (+0.00%)
XSWX:FMEMarket Closed
ListedCHF10.3BHealthcareMedical Care Facilities108,165 employees

Company Profile

Legal NameFresenius Medical Care AG
CEOMs. Helen Giza
HeadquartersElse-Kröner-Strasse 1
Phone49 6172 609 0
Employees (FTE)108,165
SectorHealthcare
IndustryMedical Care Facilities

Business Description

Fresenius Medical Care AG is a leading global healthcare company specializing in products and services for patients with renal diseases. It operates as the world's largest provider of dialysis treatments, managing a vast network of outpatient dialysis centers where it cares for hundreds of thousands of patients undergoing regular dialysis therapy to substitute kidney function in cases of chronic kidney failure. The company delivers comprehensive care through both in-center and home-based hemodialysis, peritoneal dialysis, and hospital inpatient services. Complementing its service offerings, Fresenius Medical Care AG manufactures and supplies essential dialysis products, including advanced dialysis machines, dialyzers, concentrates, and related disposables from numerous production sites worldwide. This vertically integrated model spans the entire dialysis value chain, enabling efficient delivery of high-quality solutions to healthcare providers and patients globally. Founded in 1996 and headquartered in Bad Homburg vor der Höhe, Germany, Fresenius Medical Care AG plays a pivotal role in the renal care sector, supporting millions affected by end-stage renal disease.

Profitability & Growth

Profitability

Profit Margin+4.88%
Operating Margin+8.14%
Return on Equity (TTM)+7.85%
Return on Assets (TTM)+3.63%

Recent Year-End

Revenue17.90B
Revenue / Share67.53
Gross Profit4.65B
EBITDA3.63B
Diluted EPS3.02
Earnings Growth YoY-22.30%
Revenue Growth YoY-5.50%

Balance Sheet Snapshot

Total Cash (MRQ)

1.15B

Total Debt (MRQ)

10.21B

Current Ratio (MRQ)

1.21

Book Value / Share

45.22

Stock Statistics

Shares Outstanding270.1M
Float Shares183.8M
Avg Volume (10d)250
Avg Volume (90d)83
% Held by Insiders+31.23%
% Held by Institutions+49.11%

Valuation

Market Cap10.26B
Enterprise Value19.45B
Trailing P/E10.92
Price / Sales (TTM)0.46
Price / Book (MRQ)0.73
EV / Revenue1.09
EV / EBITDA8.11

Price Summary

52-Week Low32.99
52-Week High38.59
50-Day MA35.72
200-Day MA35.75
Beta0.82

Dividends

Forward Div Rate1.36
Forward Div Yield+3.57%
Trailing Div Rate1.49
5Y Avg Div Yield+129.00%
Ex-Dividend Date2026-05-22